BMJ 1994;308:1249-1250 (14 May)
Editorials
New approaches to treating oesophageal cancer
Currently the prognosis for patients with oesophageal cancer is poor. On the basis of a review of 122 articles published between 1954 and 1978 Earlam and Cunha-Melo estimated that of 100 patients with squamous cell carcinoma of the oesophagus, 58 had exploratory surgery, of whom 39 had surgical resection and 26 left the hospital with their tumours excised. Eighteen patients were alive at one year, nine at two years, and four at five years.1 The reasons for such poor surgical results include inadequate preoperative staging and the morbidity and mortality of treatment. The most important explanation, however, is that most cases of oesophageal cancer have metastasised by the time that symptoms develop.2
Squamous cell carcinoma has been the predominant histological subtype,3 but the incidence of oesophageal adenocarcinoma is now rising in Britain4 and the United States.5 Although resectability and survival for both histological types are similar,6 reports of their relative . . . [Full text of this article]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Articles
-
Treatment of oesophageal cancer
- Fayek Salama, David Beggs, and Ellis Morgan
BMJ 1994 309: 125-126.
[Extract]
[Full Text]
-
Patients are unwilling to enter randomised trials
- T C B Dehn
BMJ 1994 309: 126.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Forgacs, I.
(1995). Recent Advances: Clinical gastroenterology. BMJ
310: 113-116
[Full text]
-
Donnelly, R J, Girling, D J, Fayers, P M
(1994). Cancer of the upper gastrointestinal tract. BMJ
308: 1716-1717
[Full text]
Rapid Responses:
Read all Rapid Responses
- Oesophageal Cancer Clinical Trials
- Abd H Mat Sain
bmj.com, 19 Apr 2003
[Full text]